BLOOMFIELD HILLS, Mich., Feb. 11, 2016 -- TriMas Corporation (NASDAQ:TRS) – a diversified global manufacturer of engineered and applied products – announced today that it will host its fourth quarter and full year 2015 earnings conference call on Thursday, February 25, 2016. The conference call will begin at 10 a.m. Eastern Time and will follow the Company’s release of fourth quarter and full year 2015 earnings results at 8 a.m. that day.
To participate on the earnings conference call, please dial: (888) 481-2877 (Conference ID #4461698) and ask to be connected to the TriMas fourth quarter and full year 2015 earnings conference call. The conference call will also be simultaneously webcast via TriMas’ website at www.trimascorp.com, under the “Investors” section, with an accompanying slide presentation.
If you are unable to participate during the live teleconference, a replay of the conference call will be available beginning February 25 at 3 p.m. Eastern Time through March 3 at 3 p.m. Eastern Time. To access the replay, please dial: (888) 203-1112 (Replay Passcode #4461698) or visit the “Investors” section of the Company’s website.
About TriMas
Headquartered in Bloomfield Hills, Michigan, TriMas Corporation (NASDAQ:TRS) provides engineered and applied products for growing markets worldwide. TriMas is organized into four reportable segments: Packaging, Aerospace, Energy and Engineered Components. TriMas has approximately 4,000 employees at more than 50 facilities in 16 countries. For more information, visit www.trimascorp.com.
CONTACT: Christine Parker Manager, Investor Relations & Communications (248) 631-5438 [email protected]


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Italy Fines Apple €98.6 Million Over App Store Dominance
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 



